SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001396814-16-000023
Filing Date
2016-08-04
Accepted
2016-08-04 15:10:00
Documents
70
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pcrx-6302016x10xq.htm 10-Q 1037743
2 EXHIBIT 10.1 pcrx-63016xex101.htm EX-10.1 60416
3 EXHIBIT 31.1 pcrx-63016xex311.htm EX-31.1 14789
4 EXHIBIT 31.2 pcrx-63016xex312.htm EX-31.2 14806
5 EXHIBIT 32.1 pcrx-63016xex321.htm EX-32.1 5629
6 EXHIBIT 32.2 pcrx-63016xex322.htm EX-32.2 5537
  Complete submission text file 0001396814-16-000023.txt   5673952

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT pcrx-20160630.xml EX-101.INS 1178989
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20160630.xsd EX-101.SCH 42945
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcrx-20160630_cal.xml EX-101.CAL 67961
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcrx-20160630_def.xml EX-101.DEF 185709
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20160630_lab.xml EX-101.LAB 603581
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20160630_pre.xml EX-101.PRE 326665
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35060 | Film No.: 161807001
SIC: 2834 Pharmaceutical Preparations